Pentraxin-3 in Thrombolytic Therapy for Acute Ischemic Stroke: No Relation with Curative Effect and Prognosis.
CONCLUSIONS PTX3 is not suitable to serve as an indicator of thrombolytic efficacy and had no association with long-term prognosis in stroke patients receiving thrombolytic therapy.
PMID: 29949524 [PubMed - in process]
Source: Medical Science Monitor - Category: Research Tags: Med Sci Monit Source Type: research
More News: Angiography | Biomedical Science | Brain | Computers | Ischemic Stroke | Neurology | Neuroscience | Perfusion | Research | Science | Stroke | Study | Thrombolytic Therapy | Thrombosis